What is the best treatment pathway for newly diagnosed endometriosis according to local University Hospitals Sussex guidelines?

Tripdatabase
2026 · doi:10.5281/zenodo.22231348 · W7204952328
Guideline OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-04 ⓘ

University Hospitals Sussex guidelines for newly diagnosed endometriosis recommend initiating treatment with hormonal therapies like contraceptives or progestogens, reserving GnRH agonists or surgery for persistent symptoms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-04 · read from full text ⓘ

This paper outlines the treatment pathway for newly diagnosed endometriosis as defined by local guidelines from University Hospitals Sussex. The recommended approach initiates with hormonal therapies, including contraceptives or progestogens, to manage initial symptoms. If these conservative measures fail to provide adequate relief, the protocol advises progression to GnRH agonists or surgical intervention. This paper is centrally about endometriosis — specifically the stepwise clinical management of newly diagnosed cases according to regional hospital protocols.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Guidelines from University Hospitals Sussex for newly diagnosed endometriosis recommend beginning with hormonal therapies such as contraceptives or progestogens, progressing to GnRH agonists or surgery if symptoms persist.
Full text 592 characters · extracted from oa-doi-fallback · click to expand
Published September 1, 2026 | Version v1 Other Open What is the best treatment pathway for newly diagnosed endometriosis according to local University Hospitals Sussex guidelines? Description Guidelines from University Hospitals Sussex for newly diagnosed endometriosis recommend beginning with hormonal therapies such as contraceptives or progestogens, progressing to GnRH agonists or surgery if symptoms persist. Files 9efab569-366a-4f42-abe3-c1321e02cb21.pdf Files (18.6 kB) | Name | Size | Download all | |---|---|---| | md5:b9f308be498ef9512af564be7a1590df | 18.6 kB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-10-07T06:01:52.021920+00:00
License: CC0 · commercial use OK